Figure S4 from A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors Mari C. Vázquez-Borrego , Vandana Gupta , Alejandro Ibáñez-Costa , Manuel D. Gahete , Eva Venegas-Moreno , Álvaro Toledano-Delgado , David A. Cano , Cristóbal Blanco-Acevedo , Rosa Ortega-Salas , Miguel A. Japón , Ana Barrera-Martín , Alexandre Vasiljevic , Jason Hill , Shengwen Zhang , Heather Halem , Juan Solivera , Gérald Raverot , María A. Gálvez , Alfonso Soto-Moreno , Marcelo Paez-Pereda , Michael D. Culler , Justo P. Castaño , Raúl M. Luque crossref（2023）
摘要
Cell viability in response to SST3-agonists and antagonists in NFPTs primary cell cultures, measured by Alamar-blue reduction.
更多 查看译文
AI 理解论文
溯源树
样例
